[Therapy of lymphocytic infiltration].
Bahmer
F A
FA
Universitätshautklinik, Homburg/Saar.
D001379:Azathioprine / Q000627:therapeutic use; D002991:Clofazimine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D006801:Humans; D007978:Levamisole / Q000627:therapeutic use; D008218:Lymphocytosis / Q000188:drug therapy* / Q000473:pathology; D012867:Skin / Q000473:pathology; D012871:Skin Diseases / Q000188:drug therapy* / Q000473:pathology; D013792:Thalidomide / Q000627:therapeutic use
D007978:Levamisole; D013792:Thalidomide; D016572:Cyclosporine; D003622:Dapsone; D002991:Clofazimine; D001379:Azathioprine
Therapie bei lymphozytischer Infiltration.